Cargando…
Wnt/β-catenin signaling: Causes and treatment targets of drug resistance in colorectal cancer
Colorectal cancer (CRC) is the third most common malignant tumor in humans. Chemotherapy is used for the treatment of CRC. However, the effect of chemotherapy remains unsatisfactory due to drug resistance. Growing evidence has shown that the presence of highly metastatic tumor stem cells, regulation...
Autores principales: | Zhu, Gui-Xian, Gao, Dian, Shao, Zhao-Zhao, Chen, Li, Ding, Wen-Jie, Yu, Qiong-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723170/ https://www.ncbi.nlm.nih.gov/pubmed/33300082 http://dx.doi.org/10.3892/mmr.2020.11744 |
Ejemplares similares
-
Wnt2 complements Wnt/β-catenin signaling in colorectal cancer
por: Jung, Youn-Sang, et al.
Publicado: (2015) -
Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2
por: Xiu, Dian-Hui, et al.
Publicado: (2019) -
Wnt/β-Catenin Signaling Pathway in the Development and Progression of Colorectal Cancer
por: He, Kuang, et al.
Publicado: (2023) -
Correction to: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2
por: Xiu, Dian-Hui, et al.
Publicado: (2021) -
Retraction Note: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2
por: Xiu, Dian-Hui, et al.
Publicado: (2021)